278 related articles for article (PubMed ID: 18461290)
1. Spontaneous remission of "methotrexate-associated lymphoproliferative disorders" after discontinuation of immunosuppressive treatment for autoimmune disease. Review of the literature.
Rizzi R; Curci P; Delia M; Rinaldi E; Chiefa A; Specchia G; Liso V
Med Oncol; 2009; 26(1):1-9. PubMed ID: 18461290
[TBL] [Abstract][Full Text] [Related]
2. Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases.
Salloum E; Cooper DL; Howe G; Lacy J; Tallini G; Crouch J; Schultz M; Murren J
J Clin Oncol; 1996 Jun; 14(6):1943-9. PubMed ID: 8656264
[TBL] [Abstract][Full Text] [Related]
3. Treatment of advanced stage methotrexate-associated lymphoproliferative disorders (MTX-LPDs) with methotrexate discontinuation.
Ross Y; Kamran M
BMJ Case Rep; 2018 Dec; 11(1):. PubMed ID: 30567235
[TBL] [Abstract][Full Text] [Related]
4. Methotrexate-related Epstein-Barr virus-associated lymphoproliferative disorder occurring in the gingiva of a patient with rheumatoid arthritis.
Ishida M; Hodohara K; Yoshii M; Okuno H; Horinouchi A; Nakanishi R; Harada A; Iwai M; Yoshida K; Kagotani A; Yoshida T; Okabe H
Int J Clin Exp Pathol; 2013; 6(10):2237-41. PubMed ID: 24133604
[TBL] [Abstract][Full Text] [Related]
5. Association of Epstein-Barr virus with regression after withdrawal of immunosuppressive drugs and subsequent progression of iatrogenic immunodeficiency-associated lymphoproliferative disorders in patients with autoimmune diseases.
Fujimoto K; Hatanaka KC; Hatanaka Y; Kasahara I; Yamamoto S; Tsuji T; Nakata M; Takakuwa Y; Haseyama Y; Oyamada Y; Yonezumi M; Suzuki H; Sakai H; Noguchi H; Mori A; Nishihara H; Teshima T; Matsuno Y
Hematol Oncol; 2020 Dec; 38(5):799-807. PubMed ID: 32798315
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological analysis of methotrexate-associated lymphoproliferative disorders: Comparison of diffuse large B-cell lymphoma and classical Hodgkin lymphoma types.
Gion Y; Iwaki N; Takata K; Takeuchi M; Nishida K; Orita Y; Tachibana T; Yoshino T; Sato Y
Cancer Sci; 2017 Jun; 108(6):1271-1280. PubMed ID: 28380678
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous Regression of Methotrexate-related Lymphoproliferative Disorder with T-cell Large Granular Lymphocytosis.
Ureshino H; Kadota C; Kurogi K; Miyahara M; Kimura S
Intern Med; 2015; 54(17):2235-9. PubMed ID: 26328653
[TBL] [Abstract][Full Text] [Related]
8. Spontaneous regression of breast lymphoproliferative disorders after withdrawal of methotrexate in rheumatoid arthritis patients with Epstein-Barr virus infection: a case report and review of the literature.
Ogawa A; Nakagawa T; Kumaki Y; Hosoya T; Oda G; Mori M; Fujioka T; Kubota K; Onishi I; Uetake H
J Med Case Rep; 2022 Feb; 16(1):49. PubMed ID: 35125110
[TBL] [Abstract][Full Text] [Related]
9. EBV-induced lymphoproliferative disorders in rheumatic patients: A systematic review of the literature.
Berti A; Felicetti M; Peccatori S; Bortolotti R; Guella A; Vivaldi P; Morelli L; Barabareschi M; Paolazzi G
Joint Bone Spine; 2018 Jan; 85(1):35-40. PubMed ID: 28196776
[TBL] [Abstract][Full Text] [Related]
10. Skin-Limited, Methotrexate-Associated Epstein-Barr Virus-Positive Mucocutaneous Ulcer-A Mimicker of High-Grade Lymphoma. A Report of 4 Cases and Review of the Literature.
Macklin PS; Fisher R; Stonard C; Matin RN; Ieremia E
Am J Dermatopathol; 2023 Aug; 45(8):519-531. PubMed ID: 37462204
[TBL] [Abstract][Full Text] [Related]
11. Primary cutaneous methotrexate-associated B-cell lymphoproliferative disorders other than EBV-positive mucocutaneous ulcer: clinical, pathological, and immunophenotypic features.
Satou A; Banno S; Kohno K; Takahara T; Takahashi E; Nobata H; Iwagaitsu S; Watanabe D; Hanamura I; Takami A; Ito Y; Nakamura S; Tsuzuki T
Pathology; 2021 Aug; 53(5):595-601. PubMed ID: 33618861
[TBL] [Abstract][Full Text] [Related]
12. Methotrexate-associated Lymphoproliferative Disorders in Patients With Rheumatoid Arthritis: Clinicopathologic Features and Prognostic Factors.
Kurita D; Miyoshi H; Ichikawa A; Kato K; Imaizumi Y; Seki R; Sato K; Sasaki Y; Kawamoto K; Shimono J; Yamada K; Muto R; Kizaki M; Nagafuji K; Tamaru JI; Tokuhira M; Ohshima K
Am J Surg Pathol; 2019 Jul; 43(7):869-884. PubMed ID: 31116708
[TBL] [Abstract][Full Text] [Related]
13. Methotrexate-associated lymphoproliferative disorder in the stomach and duodenum: a case report.
Toyonaga H; Fukushima M; Shimeno N; Inokuma T
BMC Gastroenterol; 2019 Apr; 19(1):62. PubMed ID: 31023238
[TBL] [Abstract][Full Text] [Related]
14. Retrospective analyses of other iatrogenic immunodeficiency-associated lymphoproliferative disorders in patients with rheumatic diseases.
Kaji D; Kusakabe M; Sakata-Yanagimoto M; Makishima K; Suehara Y; Hattori K; Ota Y; Mitsuki T; Yuasa M; Kageyama K; Taya Y; Nishida A; Ishiwata K; Takagi S; Yamamoto H; Asano-Mori Y; Ubara Y; Izutsu K; Uchida N; Wake A; Taniguchi S; Yamamoto G; Chiba S
Br J Haematol; 2021 Nov; 195(4):585-594. PubMed ID: 34558064
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of rheumatoid arthritis with immunodeficiency-associated lymphoproliferative disorders to regress spontaneously by the withdrawal of methotrexate and their clinical course: A retrospective, multicenter, case-control study.
Kuramoto N; Saito S; Fujii T; Kaneko Y; Saito R; Tanaka M; Takada H; Nakano K; Saito K; Sugimoto N; Sasaki S; Harigai M; Suzuki Y
Mod Rheumatol; 2022 Jan; 32(1):24-31. PubMed ID: 33496194
[TBL] [Abstract][Full Text] [Related]
16. Primary hepatic methotrexate-associated lymphoproliferative disorder associated with Epstein-Barr virus reactivation and accompanied by spontaneous necrosis: A case report.
Omameuda T; Miyato H; Sata N; Lefor AK
Medicine (Baltimore); 2022 Nov; 101(47):e31993. PubMed ID: 36451467
[TBL] [Abstract][Full Text] [Related]
17. Diffuse Large B-cell Lymphoma with Adrenal Involvement Presenting as Other Iatrogenic Immunodeficiency-associated Lymphoproliferative Disorders: Sustained Remission with Methotrexate Termination Alone in Two Cases.
Yasuda H; Ando J; Yoshida S; Ota Y; Komatsu N; Ando M
Intern Med; 2023 Feb; 62(4):601-604. PubMed ID: 35793959
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus-related lymphoma in rheumatoid arthritis: implications for long-term usage of immunosuppressive drugs and review of the literature.
He J; Williamson L; Cai K; Wong P; Sturgess A; Taper J; Manolios N
Intern Med J; 2022 Oct; 52(10):1717-1723. PubMed ID: 34028145
[TBL] [Abstract][Full Text] [Related]
19. Methotrexate-associated lymphoproliferative disorder demonstrating composite lymphoma of EBV-negative diffuse large B-cell lymphoma and EBV-positive mucocutaneous ulcer.
Moriya K; Kikuti YY; Carreras J; Kondo Y; Shiraiwa S; Nakamura N
J Clin Exp Hematop; 2020; 60(1):11-16. PubMed ID: 32224560
[TBL] [Abstract][Full Text] [Related]
20. Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication.
Hoshida Y; Xu JX; Fujita S; Nakamichi I; Ikeda J; Tomita Y; Nakatsuka S; Tamaru J; Iizuka A; Takeuchi T; Aozasa K
J Rheumatol; 2007 Feb; 34(2):322-31. PubMed ID: 17117491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]